Special Survey for Patients With Type 1 or Type 2 Diabetes
NCT01538589 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1582
Last updated 2016-03-07
Summary
This study is conducted in Japan. The aim of this study is to evaluate the incidence of severe hypoglycaemia under normal clinical practice.
Conditions
- Diabetes
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
Interventions
- DRUG
-
insulin aspart
Prescribed by the physicians as a result of normal clinical practice
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-12-31
- Primary Completion
- 2009-10-31
- Completion
- 2009-10-31
Countries
- Japan
Study Locations
More Related Trials
-
Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin Treatment
NCT00213070 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2 Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)
NCT02628392 ·Status: COMPLETED ·Phase: NA
-
Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus"
NCT03555591 ·Status: COMPLETED
-
Pharmacodynamics, Pharmacokinetics, and Safety of ASP1941 in Patients With Type 1 Diabetes Mellitus
NCT02529449 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus
NCT00530309 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes Mellitus
NCT01294436 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Patients With Type 2 Diabetes Mellitus
NCT02589639 ·Status: COMPLETED ·Phase: PHASE4
-
Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"
NCT02221284 ·Status: COMPLETED
-
Double-Blind Study of Miglitol in Japanese With type2 Diabetes
NCT00380822 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess Safety and Efficacy of ASP1941 in Combination With Nateglinide in Type 2 Diabetic Patients
NCT01316107 ·Status: COMPLETED ·Phase: PHASE3
-
Investigation on Safety, Tolerability, and Pharmacokinetics of Single Doses of NNC0113-0987 in Healthy Male Subjects
NCT01690169 ·Status: COMPLETED ·Phase: PHASE1
-
Long Term Daily Use of JARDIANCE® Tablets in Japanese Patients With Type 2 Diabetes Mellitus
NCT02489942 ·Status: COMPLETED
-
Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and 50 in Subjects With Type 2 Diabetes
NCT01620424 ·Status: COMPLETED ·Phase: PHASE1
-
Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)
NCT02291874 ·Status: COMPLETED ·Phase: PHASE4
-
Metformin Add-on Regimen Comparison Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431A-136)
NCT01545388 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess Drug-Drug Interaction Between ASP1941 and Miglitol
NCT01099839 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes Mellitus
NCT02897219 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes
NCT04809220 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Pharmacokinetics and Pharmacodynamics of DSP-8658 in Patients With Type 2 Diabetes Mellitus and Healthy Adults
NCT01042106 ·Status: COMPLETED ·Phase: PHASE1
-
A Cohort Study of Incretin-based Therapy Combined With Insulin in Type 2 Diabetic Patients for 5 Years
NCT01681550 ·Status: UNKNOWN ·Phase: NA
-
A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Participants With Type 2 Diabetes
NCT03315780 ·Status: COMPLETED ·Phase: PHASE4
-
To Study Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1656 in Japanese Type 2 Diabetes Mellitus (T2DM) Patients
NCT00916604 ·Status: COMPLETED ·Phase: PHASE1
-
Meta-analysis in Post-marketing Surveillances for SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
NCT02284269 ·Status: UNKNOWN
-
Study of HTD4010 in Healthy Volunteers
NCT02538848 ·Status: COMPLETED ·Phase: PHASE1
-
Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes Mellitus
NCT01964963 ·Status: COMPLETED